Docetaxel

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

96 API Suppliers, 40 USDMF, 28 CEP/COS, 10 JDMF, 11 EU WC, 16 KDMF, 15 NDC API, 42 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

295 Drugs in Development

295 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

370 FDF Dossiers, 87 FDA Orange Book, 167 Europe, 4 Canada, 8 Australia, 34 South Africa, 70 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 20MG/0.5ML (40MG/ML), INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 80MG/2ML (40MG/ML), INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 20MG/VIAL, INJECTABLE;INJECTION - 80MG/VIAL

RELATED EXCIPIENT COMPANIES

1 Boai NKY Pharmaceuticals Ltd, 3 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 2 Actylis, 2 BASF, 1 CD Formulation, 1 Clariant, 1 Finar, 3 Gangwal Chemicals, 1 Nanjing Bold Chemical, 6 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Solubilizers, 10 Parenteral, 7 Thickeners and Stabilizers, 7 Topical, 4 Surfactant & Foaming Agents, 4 Emulsifying Agents, 4 Film Formers & Plasticizers, 2 Rheology Modifiers, 1 Coating Systems & Additives, 1 API Stability Enhancers, 1 Co-Processed Excipients, 1 Direct Compression, 1 Taste Masking